Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

4-methylthiobenzoic acid

Known as: 4-MTBA 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Several experimental parameters affecting surface enhanced Raman (SER) signals using 488, 785 and 1064 nm excitation for eight… Expand
Is this relevant?
2005
2005
The antitumor agent cisplatin has dose-limiting side effects such as ototoxicity. Systemical co-treatment with anti-oxidants like… Expand
Is this relevant?
2005
2005
4-Methylthioamphetamine (4-MTA) is a scheduled designer drug that has appeared on the illicit drug market and led to several non… Expand
Is this relevant?
2003
2003
Several cases of death associated with 4-methylthioamphetamine (4-MTA) have raised public concern about the abuse of this… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
HYPOTHESIS The goals of this investigation were to compare the efficacy of three protective agents against cisplatin-induced… Expand
Is this relevant?
1999
1999
The purpose of this study was to investigate the effectiveness of 4-methylthiobenzoic acid (MTBA) as a protection agent against… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
HYPOTHESIS Cisplatin causes the generation of reactive oxygen species (ROS), which interferes with the antioxidant defense system… Expand
Is this relevant?
1997
1997
This study was undertaken in order to determine the changes in auditory brainstem-evoked responses relationship with the changes… Expand
Is this relevant?
1996
1996
This study investigates the changes in renal antioxidant system after cisplatin administration and the nephroprotection with 4… Expand
Is this relevant?
1991
1991
Administration of 4-methylthiobenzoic acid (MTBA) (100 mg/kg) strongly reduced cisplatin nephrotoxicity (7.5 mg/kg, 20 min after… Expand
Is this relevant?